Latest Patient Square Capital LP Stock Portfolio
Patient Square Capital LP Performance:
2025 Q3: 29.95%YTD: 31.72%2024: -9.94%
Performance for 2025 Q3 is 29.95%, and YTD is 31.72%, and 2024 is -9.94%.
About Patient Square Capital LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Patient Square Capital LP reported an equity portfolio of $373.9 Millions as of 30 Sep, 2025.
The top stock holdings of Patient Square Capital LP are ROIV, INSM, EYPT. The fund has invested 50.5% of it's portfolio in ROIVANT SCIENCES LTD and 12.6% of portfolio in INSMED INC.
The fund managers got completely rid off CULLINAN THERAPEUTICS, INC. (CGEM), SCHOLAR ROCK HOLDING CORPORATION (SRRK) and VYNE THERAPEUTICS INC. (VYNE) stocks. They significantly reduced their stock positions in LIQUIDIA CORPORATION (LQDA), ARGENX SE and KYMERA THERAPEUTICS INC (KYMR). Patient Square Capital LP opened new stock positions in ABIVAX SA, CELCUITY INC (CELC) and UNIQURE NV (QURE). The fund showed a lot of confidence in some stocks as they added substantially to CIDARA THERAPEUTICS INC (CDTX), PHARVARIS N V (PHVS) and GERON CORP (GERN).
The top stock holdings of Patient Square Capital LP are ROIV, INSM, EYPT. The fund has invested 50.5% of it's portfolio in ROIVANT SCIENCES LTD and 12.6% of portfolio in INSMED INC.
The fund managers got completely rid off CULLINAN THERAPEUTICS, INC. (CGEM), SCHOLAR ROCK HOLDING CORPORATION (SRRK) and VYNE THERAPEUTICS INC. (VYNE) stocks. They significantly reduced their stock positions in LIQUIDIA CORPORATION (LQDA), ARGENX SE and KYMERA THERAPEUTICS INC (KYMR). Patient Square Capital LP opened new stock positions in ABIVAX SA, CELCUITY INC (CELC) and UNIQURE NV (QURE). The fund showed a lot of confidence in some stocks as they added substantially to CIDARA THERAPEUTICS INC (CDTX), PHARVARIS N V (PHVS) and GERON CORP (GERN).
Patient Square Capital LP Annual Return Estimates Vs S&P 500
Our best estimate is that Patient Square Capital LP made a return of 29.95% in the last quarter. In trailing 12 months, it's portfolio return was 35.29%.
New Buys
| Ticker | $ Bought |
|---|---|
| abivax sa | 12,890,600 |
| celcuity inc | 4,940,000 |
| dianthus therapeutics inc | 4,918,750 |
| uniqure nv | 4,377,750 |
| amylyx pharmaceuticals inc | 4,298,680 |
| assembly biosciences inc | 3,460,660 |
| avalo therapeutics inc | 1,271,000 |
| perspective therapeutics inc | 1,198,180 |
New stocks bought by Patient Square Capital LP
Additions
| Ticker | % Inc. |
|---|---|
| cidara therapeutics inc | 706 |
| pharvaris n v | 41.39 |
| geron corp | 18.02 |
| allogene therapeutics inc | 13.15 |
| nurix therapeutics inc | 6.05 |
| enliven therapeutics inc | 2.03 |
Additions to existing portfolio by Patient Square Capital LP
Reductions
| Ticker | % Reduced |
|---|---|
| liquidia corporation | -60.78 |
| argenx se | -46.55 |
| kymera therapeutics inc | -33.86 |
| eyepoint pharmaceuticals inc | -25.21 |
| ocular therapeutix inc | -12.56 |
| insmed inc | -9.03 |
| mirum pharmaceuticals inc | -8.11 |
| agios pharmaceuticals inc | -4.23 |
Patient Square Capital LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| cullinan therapeutics, inc. | -6,542,790 |
| vyne therapeutics inc. | -523,104 |
| scholar rock holding corporation | -5,454,680 |
Patient Square Capital LP got rid off the above stocks
Sector Distribution
Patient Square Capital LP has about 86.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 86.9 |
| Others | 13.1 |
Market Cap. Distribution
Patient Square Capital LP has about 12.6% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 53.7 |
| SMALL-CAP | 15.1 |
| UNALLOCATED | 13.1 |
| LARGE-CAP | 12.6 |
| MICRO-CAP | 5.2 |
Stocks belong to which Index?
About 30.8% of the stocks held by Patient Square Capital LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 69.2 |
| RUSSELL 2000 | 30.8 |
Patient Square Capital LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Patient Square Capital LP
Patient Square Capital LP has 24 stocks in it's portfolio. About 85.6% of the portfolio is in top 10 stocks. NRIX proved to be the most loss making stock for the portfolio. ROIV was the most profitable stock for Patient Square Capital LP last quarter.
Last Reported on: 10 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AGIO | agios pharmaceuticals inc | 1.44 | 133,827 | 5,371,820 | reduced | -4.23 | ||
| ALLO | allogene therapeutics inc | 0.99 | 2,981,400 | 3,696,930 | added | 13.15 | ||
| AMLX | amylyx pharmaceuticals inc | 1.15 | 316,312 | 4,298,680 | new | |||
| ASMB | assembly biosciences inc | 0.93 | 135,182 | 3,460,660 | new | |||
| AVTX | avalo therapeutics inc | 0.34 | 100,000 | 1,271,000 | new | |||
| CDTX | cidara therapeutics inc | 3.10 | 121,000 | 11,587,000 | added | 706 | ||
| CELC | celcuity inc | 1.32 | 100,000 | 4,940,000 | new | |||
| CGEM | cullinan therapeutics, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| EYPT | eyepoint pharmaceuticals inc | 3.85 | 1,011,840 | 14,408,600 | reduced | -25.21 | ||
| GERN | geron corp | 0.31 | 845,000 | 1,157,650 | added | 18.02 | ||
| INSM | insmed inc | 12.57 | 326,400 | 47,004,900 | reduced | -9.03 | ||
| KYMR | kymera therapeutics inc | 1.40 | 92,592 | 5,240,710 | reduced | -33.86 | ||
| LQDA | liquidia corporation | 2.43 | 400,000 | 9,096,000 | reduced | -60.78 | ||
| MIRM | mirum pharmaceuticals inc | 2.04 | 104,262 | 7,643,450 | reduced | -8.11 | ||
| NRIX | nurix therapeutics inc | 1.08 | 437,237 | 4,040,070 | added | 6.05 | ||
| OCUL | ocular therapeutix inc | 2.24 | 715,000 | 8,358,350 | reduced | -12.56 | ||
| PHVS | pharvaris n v | 2.31 | 345,381 | 8,617,260 | added | 41.39 | ||
| QURE | uniqure nv | 1.17 | 75,000 | 4,377,750 | new | |||
| ROIV | roivant sciences ltd | 50.51 | 12,480,000 | 188,822,000 | unchanged | 0.00 | ||
| SRRK | scholar rock holding corporation | 0.00 | 0.00 | 0.00 | sold off | -100 | ||